Orlistat Administration Facilitates the Obesity Treatment Among Obese PCOS Women
In a randomized clinical trial study, 80 obese women with BMI≥30, oligomenorrhae, hirsutism
and presence of > 12 ovarian follicles (2-10mm diameter), were evaluated. In metformin group
, metformin was administered for patients 1500 mg daily for three months. In orlistate
group, patients used orlistat tablets (120 mg, 3 times a day) for three months. BMI, serum
LH and FSH levels, serum triglyceride and cholesterol levels and also patients' ovulation
was compared before and after treatment.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Body Mass Index (BMI)
3 months
Yes
Abbas Aflatoonian, Professor
Principal Investigator
Research and Clinical center for Infertility
Iran: Ministry of Health
616
NCT01003483
November 2008
October 2009
Name | Location |
---|